drugset / Trial / NCT00846391
A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)
RandomizedParallel-groupDouble-blindTreatment
Summary
A study to assess the safety and efficacy of MK8245 as monotherapy compared to placebo.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-08
- Completion
- 2009-08
Outcome
Outcome not reported
Stopped (Enrollment): “Study was terminated due to inability to recruit patients.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK8245 | Small molecule | 5 mg | — |
| Subject | MK8245 | Small molecule | 50 mg | — |